SKI Market

Indian Indices

Sensex

85,408.70 -116.14
( -0.14%)

Global Indices

Nasdaq

48,752.17 288.75
(0.60%)

Dow Jones

6,952.35 21.56
(0.31%)

Hang Seng

50,381.79 37.69
(0.07%)

Nikkei 225

9,870.68 -18.54
(-0.19%)

Forex

USD-INR

89.57 -0.04
(-0.05%)

EUR-INR

105.52 0.34
(0.32%)

GBP-INR

120.86 0.52
(0.43%)

JPY-INR

0.57 0.00
(0.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Jenburkt Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524731

INE354A01013

414.3867401

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

14.56

480.59

EPS(TTM)

Face Value()

Div & Yield %

74.77

1.65

Back

Vinayak Vanijya standalone net profit rises 100.00% in the June 2025 quarter

Aug 12,2025

Net profit of Vinayak Vanijya rose 100.00% to Rs 0.02 crore in the quarter ended June 2025 as against Rs 0.01 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.

85,408.70 -116.14 ( -0.14%)

48,752.17 288.75 (0.60%)

6,952.35 21.56 (0.31%)

50,381.79 37.69 (0.07%)

9,870.68 -18.54 (-0.19%)

89.57 -0.04 (-0.05%)

105.52 0.34 (0.32%)

120.86 0.52 (0.43%)

0.57 0.00 (0.60%)